Afghanistan

Bio-Thera Solutions has struck a deal with Macter International for rights to its BAT1706 biosimilar rival to Avastin (bevacizumab) in Pakistan and Afghanistan.

Afghanistan is set to immunise up to eight million children under the age of five in its final polio vaccination campaign for the year.

More than one million children were targeted in a mass polio vaccination drive in Afghanistan this week.